Blood Pressure Management Technology for High Blood Pressure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new technology system for managing high blood pressure. Participants will split into two groups to determine if the Blood Pressure Technology System E or M aids in medication adherence and effective condition management. One group will receive additional strategies for medication and blood pressure management, while both groups will receive general information about high blood pressure. The trial seeks individuals aged 65 or older who use an Apple iPhone and have struggled with consistently taking their high blood pressure medication. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance blood pressure management for many.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, it seems you will continue managing at least one hypertension medication during the study.
What prior data suggests that this blood pressure technology system is safe for managing high blood pressure?
Research shows that checking blood pressure at home is generally safe and easy. For Blood Pressure Technology System E, studies have found that digital tools effectively and safely manage high blood pressure. These tools allow users to track blood pressure over time from home, making management easier and more convenient.
For Blood Pressure Technology System M, research shows similar results. Measuring blood pressure at home is reliable and safe for regular monitoring. Using automated devices with an upper arm cuff is important, as recommended by the World Health Organization.
Both systems use technology that has been widely tested and used for managing high blood pressure. This results in a low risk of serious side effects, making these systems a safe choice for those managing high blood pressure at home.12345Why are researchers excited about this trial?
Researchers are excited about the Blood Pressure Technology Systems E and M because they offer a fresh approach to managing high blood pressure. Unlike traditional methods that often rely on medications alone, these systems provide users with comprehensive information about high blood pressure, including medication details and strategies for better medication adherence. This educational aspect empowers patients to take an active role in managing their condition, potentially leading to better outcomes. Additionally, the structured mid- and post-assessments at three and six months encourage ongoing engagement and adjustment, which could enhance long-term blood pressure control.
What evidence suggests that this blood pressure technology system is effective for managing high blood pressure?
Research shows that blood pressure monitoring systems, like those tested in this trial, can help people manage high blood pressure effectively. Participants will be assigned to one of two systems: Blood Pressure Technology System M or Blood Pressure Technology System E. Studies have found that using home blood pressure monitors with remote guidance can significantly lower blood pressure. One study found that remote monitoring improved patient health and reduced healthcare costs. For the Blood Pressure Technology System M, home monitoring has proven to be a reliable and convenient way to track blood pressure outside the doctor's office. Research also shows that checking blood pressure at home helps keep it under control better than usual care. Overall, these systems can make a real difference in managing high blood pressure.678910
Are You a Good Fit for This Trial?
This trial is for older adults aged 65 or over with high blood pressure who are not taking their hypertension medication as prescribed. Participants must be able to read and speak English, use an iPhone, manage at least one blood pressure medicine themselves, and commit to a six-month study period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the blood pressure technology system for 6 months, with mid-assessment at 3 months and post-assessment at 6 months
Follow-up
Participants are monitored for changes in adherence, blood pressure, perceived competence, autonomy, and mobile device proficiency
What Are the Treatments Tested in This Trial?
Interventions
- Blood Pressure Technology System E
- Blood Pressure Technology System M
Trial Overview
The trial tests two different blood pressure technology systems in people who struggle with medication adherence. All participants receive high blood pressure education; half also get strategies for managing medications. They're checked after three months and again at the end of the study.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
University of Illinois at Urbana-Champaign
Collaborator
Published Research Related to This Trial
Citations
Effectiveness of Home Blood Pressure Monitoring, Web ...
The e-BP study was a three-armed randomized controlled trial designed to compare two interventions to improve hypertension control. Patients who had ...
Blood pressure outcomes at 12 months in primary care ...
We compared BP-related outcomes, including hypertension control, SBP achieved, and antihypertensive medication intensification, over 12 months ...
Efficiency of remote monitoring and guidance in blood ...
In this study, we aimed to compare whether remote monitoring and self-monitoring differ from usual care in terms of their effects on BP ...
Management of Hypertension in the Digital Era
Wearable blood pressure monitors allow frequent blood pressure measurements (ideally continuous beat-by-beat monitoring of blood pressure) with minimal stress ...
5.
healthsnap.io
healthsnap.io/the-impact-of-virtual-care-management-programs-on-hypertension-outcomes-in-2024/The Impact of Virtual Care Management Programs on ...
The ability to monitor blood pressure remotely not only improves patient outcomes but also leads to significant cost savings for healthcare ...
Novel Digital Technologies for Blood Pressure Monitoring and ...
This paper reviews existing and emerging digital tools available for hypertension management, as well as behavioral economic insights that could supercharge ...
The 2020 “WHO Technical Specifications for Automated ...
A recent World Health Organization report has outlined the technical specifications for automated noninvasive clinical BP measurement with cuff.
Electronic Communications and Home Blood Pressure ...
The Electronic Communications and Home Blood Pressure Monitoring (e-BP) study is a three-arm randomized controlled trial designed to determine whether care ...
9.
healthsnap.io
healthsnap.io/why-home-blood-pressure-monitoring-is-the-gold-standard-of-care-for-hypertension-management/Why Home Blood Pressure Monitoring is The Gold ...
Home blood pressure monitoring provides actionable BP data obtained under pre-determined conditions and timeframes over an extended time period.
Home Blood Pressure Telemonitoring Technology for Patients ...
HBPT intervention is a feasible postdischarge management strategy and can be beneficial in supporting patients with asymptomatic elevated BP from the ED.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.